Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Effect of physical activity on nonmelanoma skin cancer risk in kidney, liver, and pancreatic transplant patients.

Whalen FM, Jambusaria-Pahlajani A, Speck RM, Schmitz K, Schmults CD.

Dermatol Surg. 2010 Oct;36(10):1510-3. doi: 10.1111/j.1524-4725.2010.01674.x.

PMID:
20698873
2.

Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.

Tessari G, Naldi L, Boschiero L, Nacchia F, Fior F, Forni A, Rugiu C, Faggian G, Sassi F, Gotti E, Fiocchi R, Talamini G, Girolomoni G.

Arch Dermatol. 2010 Mar;146(3):294-9. doi: 10.1001/archdermatol.2009.377.

PMID:
20231501
3.

Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.

Geusau A, Dunkler D, Messeritsch E, Sandor N, Heidler G, Rödler S, Ankersmit J, Zuckermann A, Tschachler E.

Int J Dermatol. 2008 Sep;47(9):918-25. doi: 10.1111/j.1365-4632.2008.03711.x.

PMID:
18937654
4.

Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.

Carroll RP, Ramsay HM, Fryer AA, Hawley CM, Nicol DL, Harden PN.

Am J Kidney Dis. 2003 Mar;41(3):676-83.

PMID:
12612993
5.

Nonmelanoma skin cancer after liver transplantation. Study of risk factors.

Herrero JI, España A, Quiroga J, Sangro B, Pardo F, Alvárez-Cienfuegos J, Prieto J.

Liver Transpl. 2005 Sep;11(9):1100-6.

6.

Skin surveillance of a U.K. paediatric transplant population.

Thomson MA, Suggett NR, Nightingale PG, Milford DV, Baumann U, Kelly DA, Moss C, Hill VA.

Br J Dermatol. 2007 Jan;156(1):45-50.

PMID:
17199565
7.

Predicting risk of nonmelanoma skin cancer and premalignant skin lesions in renal transplant recipients.

Urwin HR, Jones PW, Harden PN, Ramsay HM, Hawley CM, Nicol DL, Fryer AA.

Transplantation. 2009 Jun 15;87(11):1667-71. doi: 10.1097/TP.0b013e3181a5ce2e.

PMID:
19502958
8.

Cancer incidence and survival in kidney transplant patients.

Navarro MD, López-Andréu M, Rodríguez-Benot A, Agüera ML, Del Castillo D, Aljama P.

Transplant Proc. 2008 Nov;40(9):2936-40. doi: 10.1016/j.transproceed.2008.09.025.

PMID:
19010153
9.

Non-melanoma skin cancer incidence and risk factors after kidney transplantation: a Canadian experience.

Comeau S, Jensen L, Cockfield SM, Sapijaszko M, Gourishankar S.

Transplantation. 2008 Aug 27;86(4):535-41. doi: 10.1097/TP.0b013e318180482d.

PMID:
18724222
10.

Non-melanoma skin cancer risk in the Queensland renal transplant population.

Ramsay HM, Fryer AA, Hawley CM, Smith AG, Harden PN.

Br J Dermatol. 2002 Nov;147(5):950-6.

PMID:
12410706
11.

A population-based study of skin cancer incidence and prevalence in renal transplant recipients.

Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM.

Br J Dermatol. 2006 Mar;154(3):498-504.

PMID:
16445782
12.

First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.

Mackenzie KA, Wells JE, Lynn KL, Simcock JW, Robinson BA, Roake JA, Currie MJ.

Nephrol Dial Transplant. 2010 Jan;25(1):300-6. doi: 10.1093/ndt/gfp482. Epub 2009 Sep 25.

13.

Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial.

Salgo R, Gossmann J, Schöfer H, Kachel HG, Kuck J, Geiger H, Kaufmann R, Scheuermann EH.

Am J Transplant. 2010 Jun;10(6):1385-93. doi: 10.1111/j.1600-6143.2009.02997.x. Epub 2010 Feb 1.

14.

Location of nonmelanoma skin cancers in patients after kidney transplantation.

Sułowicz J, Wojas-Pelc A, Ignacak E, Janda K, Bętkowska-Prokop A, Kuźniewski M, Sułowicz W.

Pol Arch Med Wewn. 2014;124(5):233-8. Epub 2014 Apr 15.

15.

Malignancies in patients under long-term immunosuppression after kidney transplantation.

Behrend M, Kolditz M, Kliem V, Oldhafer KJ, Brunkhorst R, Frei U, Pichlmayr R.

Transplant Proc. 1997 Feb-Mar;29(1-2):834-5. No abstract available.

PMID:
9123546
16.

The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study.

Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, O'Sullivan B, Siskind V, Van Der Woude FJ, Hardie IR.

Transplantation. 1996 Mar 15;61(5):715-21.

PMID:
8607173
17.

Risk factors associated with the development of skin cancer after liver transplantation.

Mithoefer AB, Supran S, Freeman RB.

Liver Transpl. 2002 Oct;8(10):939-44.

18.

Risk of non-melanoma skin cancer in autoimmune hepatitis.

Leung J, Dowling L, Obadan I, Davis J, Bonis PA, Kaplan MM, Casey D, Viveiros K.

Dig Dis Sci. 2010 Nov;55(11):3218-23. doi: 10.1007/s10620-010-1145-1. Epub 2010 Feb 18.

PMID:
20165977
19.

Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease.

Otley CC, Cherikh WS, Salasche SJ, McBride MA, Christenson LJ, Kauffman HM.

J Am Acad Dermatol. 2005 Nov;53(5):783-90. Epub 2005 Sep 22.

PMID:
16243126
20.

Recent contributions to transplantation at the University of Cincinnati.

Alexander JW, First MR, Hariharan S, Penn I, Schroeder T, Ryckman F, Munda R, Bhat G, Bolce R.

Clin Transpl. 1991:159-78.

PMID:
1820114
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk